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Background
Potassium is an extracellular ion with an important role 
in the electrophysiologic regulation of myocardial func-
tion. Different concentrations of high intracellular and 
low extracellular potassium ions, the opposite of which is 
true for sodium ion, are maintained by sodium potassium 
adenosine triphosphatase (Na-K ATPase) pumps, giving 
rise to a resting membrane potential of −90 mV across the 
myocytes membrane. As a result, any change in extracel-
lular potassium concentration may have a significant ef-
fect on myocyte electrophysiologic gain (1).
Hyperkalemia is a prevalent and potentially fatal electro-
lyte disturbance. The incidence of Hyperkalemia in the 
general population is unknown, but it occurs in 1–10% 
of hospitalized patients, with a mortality rate of 1 in 
1,000 patients (2).
Although the electrocardiogram may show changes sug-
gestive of Hyperkalemia, diagnosis is usually based on 
laboratory studies. Hyperkalemia can be associated with 
frequent electrocardiographic abnormalities. In general, 
Hyperkalemia results in a gradual decrease in the excit-
ability and conduction velocity of specialized pacemaker 
cells and conducting tissues throughout the heart. Typical 
Electrocardiogram (ECG) findings in Hyperkalemia pro-
gress from tall, “peaked” T waves and a shortened QT in-
terval to a lengthening of PR interval and loss of P waves, 
and then to widening of the QRS complex, culminating 
in a “sine wave” morphology and death if not treated 
(3‒6). High serum potassium levels are thought to impair 
the conduction in Purkinje fibers and ventricles more 
than that in the AV node; although complete Atrioven-
tricular (AV) block can occur, it is one of the rarest initial 
presentations (7).
Case Report
The patient was a 62-year-old man who was admitted into 
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Abstract
Background: Potassium, as an extracellular ion, plays an important role in the 
electrophysiologic function of the myocardium and any change in extracellular 
concentration of this ion might have a marked impression upon myocyte 
electrophysiologic gain. High serum potassium levels are thought to impair pulse 
conduction in Purkinje fibers and ventricles more than that in the Atrioventricular 
(AV) node. Therefore, although complete AV block can occur, it is a rare initial 
presentation.
Case Report: We describe a 62-year-old man with a history of diabetes mellitus, 
ischemic heart disease and previous Coronary Artery Bypass Graft (CABG), who 
came to our emergency department due to generalized weakness starting 2 days 
before admission. The patient also had decreased force in lower limbs, exacerbating 
from the morning, and was finally diagnosed as a hyperkalemia-induced Complete 
Heart Block (CHB). It should also be noted that the patient responded dramatically 
to the administration of 10 mL of 10% calcium gluconate along with external pacing 
until potassium level correction became effective.
Conclusion: In spite of the fact that Hyperkalemia can be associated with frequent 
Electrocardiogram (ECG) abnormality, advanced heart blocks (second- and third-
degree AV blocks) are usually found only in patients with pre-existing heart 
failure, conduction abnormalities, or other cardiac diseases. Institution of effective 
treatment rapidly and forgiveness of traditional non-effective, time consumptive 
and sometimes risking full-adjustment modalities, such as sodium bicarbonate 
infusion or exchange resins that prevent their use in the emergent phase, can help 
minimize patient morbidity and mortality.
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Figure 1. a) First ECG. b) ECG after transcutaneous pacing. c) ECG after 
calcium gluconate administration
Figure 2. ECG after hemodialysis.
our emergency department due to generalized weakness, 
nausea and frequent vomiting from 2 days before and also 
decreased force in lower limbs, which had deteriorated 
since that morning. He was alert when admitted into the 
emergency department but complained of pain in left 
hemithorax accompanied by cold sweating which had be-
gun 3 hours previously.
He had a positive history of diabetes mellitus for the pre-
vious 20 years, ischemic heart disease and previous Coro-
nary Artery Bypass Graft (CABG), for the former 3 years 
as well.  He also had a history of hospital admission due 
to raised Blood Urea Nitrogen (BUN) and creatinine, and 
was treated with one time hemodialysis in the previous 
year. Nitrocontin, Spironolactone, Aspirin (ASA), Furo-
semide, Enalapril, Carvedilol and Insulin were the drugs 
that he used regularly.
When he was admitted into the emergency department he 
had a respiratory rate of 22/min, a pulse rate of 28/min, 
a blood pressure of 75/55 mmHg, and his blood sugar 
was 170 mg/dL.
His ECG revealed CHB (Figure 1a) which was immedi-
ately treated with transcutaneous pacing and atropine 
(Figure 1b).
Laboratory examination revealed the following: K= 8 mg/
dL, BUN= 110 mg/dL, creatinine= 5.13 mg/dL and Mg= 
2.6 mg/dL. Arterial Blood Gas (ABG) test results were: 
pH= 7.23, PCO2= 29.5, HCO3= 12.2 and BE= -13.8. 
Because of obvious Hyperkalemia and its apparent cardiac 
conductive effects, 10 mL of 10% calcium gluconate was 
administered immediately, which resulted in dramatic 
heart block elimination (Figure 1c).
Infusion of 50% glucose plus insulin was instituted; kayex-
alate was also administered via a nasogastric tube. He was 
prepared for hemodialysis simultaneously.
He was admitted into the CCU for the rest of the treat-
ment after hemodialysis and was discharged without any 
problems 3 days later (Figure 2).
Discussion
Although the ECG is not considered as a reliable indicator 
of mild to moderate Hyperkalemia, profound elevations 
of serum potassium concentrations generally produce 
classic ECG manifestations, but some reports are avail-
able of severe hyperkalemia (greater than 9.0 mEq/L) with 
ECGs not revealing the expected manifestations of Hy-
perkalemia. Thus, even with profound serum potassium 
elevations, the ECG cannot reliably be used to exclude Hy-
perkalemia or to monitor therapy designed to lower the 
serum potassium concentration (7,8).
CHB occurs when all the electrical transmission is lost 
from the supraventricular tissues to ventricles. The lower 
level of block, the slower and the less reliable will be the 
ventricular escape rhythm. Third-degree AV block can 
be congenital or acquired. In general, congenital third-
degree AV block is associated with a narrow complex es-
cape rhythm and fewer symptoms. Ischemic heart disease, 
drugs, and Hyperkalemia are some common causes of ac-
quired CHB. On the other hand, cardiomyopathies, myo-
carditis, structural heart disease, hypothermia, and severe 
hypothyroidism are much less common causes. Acquired 
third-degree AV block often has a wide complex escape 
rhythm, with symptoms of hypoperfusion at rest or with 
minimal exertion. CHB may be subacute/chronic and 
relatively well tolerated providing that the block occurs at 
a relatively high level, (A-V nodal to His bundle region). 
Alternatively the patient may be very unwell, usually in 
acute onset in association with myocardial ischemia or a 
low level block (8,9).
In spite of the fact that Hyperkalemia can be associated 
with frequent ECG abnormality, advanced heart blocks 
(second- and third-degree AV blocks) are usually seen 
only in patients with pre-existing heart failure, conduction 
abnormalities, or other cardiac diseases (3,4). Underlying 
coronary artery disease or diffuse cardiac diseases were 
thought to have already damaged the conduction path 
through the AV node and His-Purkinje system, and an 
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elevated potassium level only further worsened this pre-
existing conduction abnormality (4,5).
Treatment of patients with third-degree AV block depends 
on the symptoms. A temporary pacemaker will be nec-
essary in all the patients with CHB, who do not respond 
to medical intervention. Patients with clinical evidence of 
hypoperfusion are best treated with transcutaneous pac-
ing and close clinical assessment. While atropine is often 
used in the field, it rarely helps or harms, usually simply 
alters the conduction ratios without changing the escape 
rhythm. The patient should be admitted into an appropri-
ate monitoring unit if acquired or symptomatic third-de-
gree AV block is diagnosed. Initially, external pacing (via 
skin pacing pads) may be successful in urgent cases in the 
ED. This is useful as a temporary measure until the patient 
stabilizes and treatment of the underlying cause becomes 
effective or a more definitive pacemaker is placed (7,9). 
The goal of life-threatening Hyperkalemia treatment is to 
block its effects on myocyte membrane, cardiac conduc-
tion and initiation of further steps to decrease extracel-
lular potassium levels (6). Most of the current recommen-
dations emphasize that Hyperkalemia should be treated 
with the appearance of electrocardiographic changes or 
when serum potassium levels are higher than 6.5 mEq/L, 
regardless of the electrocardiogram (10).
The treatment for Hyperkalemia can be thought of in 3 
distinct steps. The first step is to antagonize the effects of 
Hyperkalemia at cellular level (membrane stabilization). 
Calcium (intravenous calcium chloride or gluconate) can 
effectively block the effect of extracellular potassium el-
evation on cardiac myocytes within minutes by restoring 
a more appropriate electrical gradient across the cellular 
membrane. The second step is to decrease serum potas-
sium levels by promoting the influx of potassium into cells 
throughout the body. Combination of Glucose and Insu-
lin, Beta-2 adrenergic agonists and Sodium bicarbonate 
drives potassium intracellularly and lowers the extracellu-
lar serum potassium level. The third step is to remove po-
tassium from the body. Excessive body potassium can be 
removed with sodium polystyrene sulfonate (kayexalate), 
whereas hemodialysis represents the definitive method to 
reduce serum potassium levels (5,6,10).
Sodium bicarbonate infusion is used with the aim of shift-
ing extracellular potassium to intracellular space by rais-
ing blood pH (11,12). In a study by Blumberg et al, no 
significant change in potassium levels occurred until 4 
hours after sodium bicarbonate administration and only 
a decrease of 0.35 mEq/L was seen after 6 hours (13). Due 
to the lack of a quick or sustained decrease in potassium 
levels, routine bicarbonate therapy for the treatment of 
Hyperkalemia is controversial and it is better to reserve 
its use for situations in which severe acidemia is present 
or there is another indication for its administration (10). 
Most studies have shown that exchange resins decrease 
serum potassium levels by about 1 mEq/L over a 24-hour 
period. Therefore, their long time requirement precludes 
their use in emergency and fatal situations. In addition, 
because of high probability of significant constipation 
induced by exchange resins, combination with a laxative, 
such as sorbitol, is ordinarily considered. Although gener-
ally safe, the combination of a resin with sorbitol has been 
reported to cause intestinal necrosis; therefore, it should 
be used cautiously and only when necessary (9,14,15). 
Conclusion
Hyperkalemia is a commonly encountered electrolyte ab-
normality that can lead to life-threatening derangements 
in cardiac conduction. The emergency medicine physician 
and specialist should be aware of the range of dysrhyth-
mia attributed to Hyperkalemia, including CHB which is 
rare but can occur, especially in patients with pre-existing 
heart failure, conduction abnormalities, or other cardiac 
diseases. Institution of effective treatment rapidly and for-
giveness of traditional non-effective, time consumptive 
and sometimes risking full adjustment modalities, such as 
sodium bicarbonate infusion or exchange resins that ex-
clude their use in the emergent phase, can help minimize 
patient morbidity and mortality.
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Summary points
▶ Why is this topic important? Hyperkalemia is one 
of the curable emergency conditions that can be 
presented with lots of manifestation.
▶ What does this study attempt to show? It tries to 
discuss one of the rare cases of hyperkalemia that 
is presented with complete heart block as a first 
manifestation.
▶ What are the key findings? We explained risk 
factors, manifestations, and also treatment options 
of hyperkalemia-induced complete heart block in a 
summary via a case presentation as an educational 
case study.
▶ How is patient care impacted? This paper reported 
a correct patient care in an emergency department 
as a guide for all emergency physicians and staff.
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